A Relative Bioavailability Study and Food Effect Study of AB521 in Healthy Adult Volunteers

Completed · Phase 1

Conditions studied: Healthy Participants

In brief

The primary purpose of this study is to compare the single-dose pharmacokinetics (PK) of casdatifan tablet versus the casdatifan capsule, and to evaluate the effect of food on the single-dose PK of casdatifan tablet in healthy adult volunteers.

Key facts

Study ID

NCT05999513

Run by

Arcus Biosciences, Inc.

People needed

24

Starts

2023-08-21

Expected to finish

2023-10-31

Last updated by the study team

2024-10-17

Who can join

Age: 19 and older, up to 55. Sex: any. Healthy volunteers: accepted.

Where it is running

• Celerion, Inc. — Lincoln, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.